Clinical research the effect of sarcopenia on erlotinib therapy in patients with metastatic adenocarcinoma

HIGHLIGHTS

• who: Lung cancer et al. from the Lung cancer is one of the most common cancers worldwideIt is the leading cause of death in both sexes [1]. Nonsmall cell lung cancer (NSCLC) represents the majority of all lung cancers. Adenocarcinoma is the most common type of lung cancer and accounts for half of all lung cancer cases [2]. Epidermal growth factor receptor (EGFR) mutations in EGFR tyrosine kinase have been detected in approximately, % of Department of Medical Oncology, Faculty of Medicine, Bezmialem Vakif University, Istanbul, Turkey Department of Medical Oncology, University of Health Sciences Istanbul, Sureyyapasa Chest . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.